Skip to main content

Table 1 Baseline characteristics of study population

From: Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya

Variables

 Age in years

  Age, median (IQR)

30 (25,36)

  Age < 30, n (%)

364 (53)

  Age 30+, n (%)

323 (47)

 Parity, n (%)

  1–4

593 (85)

  More

64 (9)

  None

44 (6)

 Contraception, n (%)

  Contraceptive Injection

220 (43)

  Intrauterine Contraceptive Device (IUCD)

122 (24)

  Contraceptive Implant

99 (19)

  Oral Contraception (OC)

61 (12)

  Bilateral Tubal Ligation (BTL)

8 (2)

  Condom

5 (1)